TAIPEI, Taiwan – Translational science specialist BRIM Biotechnology Inc. has entered a collaboration agreement with Janssen Pharmaceutica N.V., a unit of Johnson & Johnson, for research, development and commercialization of compounds identified by Janssen for dengue fever indications.